AAAAAA

   
Results: 1-15 |
Results: 15
MAYOR CORNING - ALBANY ICON, ALBANY ENIGMA - GRONDAHL,P
Authors: WEISMAN S
Citation: S. Weisman, MAYOR CORNING - ALBANY ICON, ALBANY ENIGMA - GRONDAHL,P, The New York times book review, 1998, pp. 24-24
SAFETY AND EFFICACY OF LOW-DOSE INTRAVENOUS IMMUNE GLOBULIN (IVIG) TREATMENT FOR INFANTS AND CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA
Authors: WARRIER I BUSSEL JB VALDEZ L BARBOSA J BEARDSLEY DS GROSSI M BERKOW R RADO T SIEGEL R WEINSTEIN R HENRY D WALLACH S WEISMAN S HOOTS WK ZEIGLER Z
Citation: I. Warrier et al., SAFETY AND EFFICACY OF LOW-DOSE INTRAVENOUS IMMUNE GLOBULIN (IVIG) TREATMENT FOR INFANTS AND CHILDREN WITH IMMUNE THROMBOCYTOPENIC PURPURA, Journal of pediatric hematology/oncology, 19(3), 1997, pp. 197-201
DUAL DIAGNOSIS SUBTYPES IN URBAN SUBSTANCE-ABUSE AND MENTAL-HEALTH CLINICS
Authors: HIEN D ZIMBERG S WEISMAN S FIRST M ACKERMAN S
Citation: D. Hien et al., DUAL DIAGNOSIS SUBTYPES IN URBAN SUBSTANCE-ABUSE AND MENTAL-HEALTH CLINICS, Psychiatric services, 48(8), 1997, pp. 1058-1063
PREMEDICATION IN THE UNITED-STATES - A STATUS-REPORT
Authors: KAIN ZN MAYES LC BELL C WEISMAN S HOFSTADTER MB RIMAR S
Citation: Zn. Kain et al., PREMEDICATION IN THE UNITED-STATES - A STATUS-REPORT, Anesthesia and analgesia, 84(2), 1997, pp. 427-432
USE OF PREMEDICATION IN THE UNITED-STATES - STATUS-REPORT ON ADULT PATIENTS
Authors: KAIN ZN BELL C RIMAR S WEISMAN S HOFSTADTER MB MCGOLDRICK K
Citation: Zn. Kain et al., USE OF PREMEDICATION IN THE UNITED-STATES - STATUS-REPORT ON ADULT PATIENTS, Anesthesia and analgesia, 84, 1997, pp. 11-11
USE OF PREMEDICATION IN THE UNITED-STATES - STATUS-REPORT ON PEDIATRIC-PATIENTS
Authors: KAIN ZN BELL C RIMAR S WEISMAN S HOFSTADTER MB MAYES L
Citation: Zn. Kain et al., USE OF PREMEDICATION IN THE UNITED-STATES - STATUS-REPORT ON PEDIATRIC-PATIENTS, Anesthesiology, 85(3A), 1996, pp. 1070-1070
SIDE-EFFECTS WITH USE OF ORAL TRANSMUCOSAL FENTANYL - REPLY
Authors: SCHECHTER NL BERNSTEIN B WEISMAN S ROSENBLUM M CONARD PL
Citation: Nl. Schechter et al., SIDE-EFFECTS WITH USE OF ORAL TRANSMUCOSAL FENTANYL - REPLY, Pediatrics, 96(3), 1995, pp. 544-544
THE GLYCOPROTEIN-IB-IX COMPLEX-SPECIFIC MONOCLONAL-ANTIBODY SZ1 BINDSTO A CONFORMATION-SENSITIVE EPITOPE ON GLYCOPROTEIN-IX - IMPLICATIONSFOR THE TARGET ANTIGEN OF QUININE QUINIDINE-DEPENDENT AUTOANTIBODIES/
Authors: LOPEZ JA LI CQ WEISMAN S CHAMBERS M
Citation: Ja. Lopez et al., THE GLYCOPROTEIN-IB-IX COMPLEX-SPECIFIC MONOCLONAL-ANTIBODY SZ1 BINDSTO A CONFORMATION-SENSITIVE EPITOPE ON GLYCOPROTEIN-IX - IMPLICATIONSFOR THE TARGET ANTIGEN OF QUININE QUINIDINE-DEPENDENT AUTOANTIBODIES/, Blood, 85(5), 1995, pp. 1254-1258
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Authors: ALTMAN R CARRERAS L DIAZ R FIGUEROA E PAOLASSO E PARODI JC CADE JF DONNAN G EADIE MJ GAVAGHAN TP OSULLIVAN EF PARKIN D RENNY JTG SILAGY C VINAZZER H ZEKERT F ADRIAENSEN H BERTRANDHARDY JM BRAN M DAVID JL DRICOT J LAVENNEPARDONGE E LIMET R LOWENTHAL A MORIAU M SCHAPIRA S SMETS P SYMOENS J VERHAEGHE R VERSTRAETE M ATALLAH A BARNETT H BATISTA R BLAKELY J CAIRNS JA COTE R CROUCH J EVANS G FINDLAY JM GENT M LANGLOIS Y LECLERC J NORRIS J PINEO GF POWERS PJ ROBERTS R SCHWARTZ L SICURELLA J TAYLOR W THEROUX P TURPIE AG WEISEL RD CUI J LIU L PIRK J BAY C BOYSEN G KNUDSEN JB PETERSEN P SORENSEN PS TONNESEN HK HARJOLA PT ARCAN JC BALKAU B BLANCHARD J BOISSEL JP BONEU B BOUSSER MG BROCHIER M CLOAREC M CRIBIER G DECHAVANNE M DROUIN P ESCHWEGE E GUIRAUDCHAUMEIL B HUGONOT R LEIZOROVICZ A LORIA Y MICHAT L MIROUZE J PANAK E PASTEYER J RASCOL A REVOL L ROY M SELLES J SLAMA G STARKMAN C TEULE M THIBULT N VERRY M ALBERT FW ANDRASSY K BREDDIN K ECKEL R ENCKE A FROHLICH J HARTUNG B HEISS HW HESS H HOFLING B KRAUSE D LATTA G LINKE H LOEW D LORENZ R MIDDLETON K NOVAK G OLDENDORF M PFLUGER N RAITHEL D REUTER R SCHETTLER G SCHNITKER J SCHOOP W STIEGLER H UBERLA K VOGEL G WEBER M WELBERS I ZEITLER E ARAPAKIS G CHAN T MOK CK SZABO R MISRA NP REDDY K FITZGERALD GA APOLLONIO A BALSANO F BASELLINI A CANDELISE L CATALANO M CIAVARELLA N CIUFFETTI G COCCHERI S CORTELLARO M CORVI G COTO V DAVI G DECATERINA R DIPERRI T FIESCHI C GENTILE R GREGORATTI L GRESELE P LAVEZZARI M LIBRETTI A MAGNANI B NENCI G PAGANO G PATRONO C PEDRINI L PINI M PRANDONI P ROMEO F ROVELLI F RUDELLI G RUVOLO G SIGNORINI GP TOGNONI G VIOLI F FUJIMORI T KAGEYAMA M KATSUMURA T KITAMURA S MAEDA K SUZUKI A TOHGI H UCHIYAMA S UTSUMI H GARCIA AM ALGRA A DENOTTOLANDER GJH KUPPER AJF VANGIJN J HART H KAPPELLE LJ KOUDSTAAL PJ LEMMENS T LODDER J PANNEBAKKER M SERRUYS PW VANDENBELT A VANDERMEER J VANDERVIJGH AB VERHEUGT FWA VETH G DALE J JOHANNESSEN KA THAULOW E POPESCU P TIBERIU N AZNAR JRD ESMATJES E GUITERAS P LASIERRA J LOPEZTRIGO P ORIOL A POMAR L ROCHA E SANCHEZ FD SANCHORIEGER J SANZ G BERGLUND ULF BLOMSTRAND C BOBERG M BRITTON M ELWIN CE HELMERS C HOLM J JANZON L JUULMOLLER S MULEC H OLSSON JE PERSSON S RASMANIS G ROSEN A SAMUELSSON K SOREFF J WAHLGREN N WALLENTIN L BAUR HR BOKSLAG M BOLLINGER A MEIER B PFISTERER M PFLUGER N SITTHIAMORN C ACHESON EJ APPLEBY P ASSCHER AW AUKLAND A BAIGENT C BALA S BARNETT AH BELL P BEWS S BORN GVR BRANAGAN JP BROOKS N BROWN MJ BROWSE NL CAPILDEO R CARMALT M CARTER AE CHALMERS I CLARKE M CLARKE RJ CLYNE CAC COLLINS R COOKE ED COUTTS G COVE DH CROWTHER PS CUTHBERTSON WF DEBONO D DICKERSON C DICKINSON JP DOLL R DORMANDY JA DUNBABIN D ELL S ELPHINSTONE P ELWOOD P ENGLISHBY V FARRELL B FISKERSTRAND C FLATHER M FOLEY T FOULDS T FOX KM FRANKS P FRASER H GARDECKI T GAWEL M GENT AE GERSHLICK AH GODWIN J GOLDMAN M GRAY C GRAY D GRAY R HANDOLL H HANKEY G HARRISON MJG HENDERSON N HEPTINSTALL S HOBBIGER SF JONES EW JONES NAG JOST S JULIAN D KELLETT J KESTER RC LOWE G MACKENZIE J MCCOLLUM CN MEAD G MEADE TW MENDELOW D MILLER JC MORRIS GK NICHOL C NOBLE M OBRIEN JR OGIER M PARISH S PARRY MJ PETO R POWELL J POZZILLI P QIZILBASH N RAHMAN A RAJAH SM RICHARDS DH RICHARDS S RIPLEY R ROBERTS VC ROSE FC RUSSELL RWR RUBIN PC RUCKLEY CV SANDERCOCK P SHAW MDM SHAW KM SHELLEY JH SLATTERY J SLEIGHT P SMITH SJ STEWARTLONG P SWEETNAM PM TANSEY MJB TINDALL H TURNEY J TYLER HM VAREY NC VESSEY MP WALKER MG WALKER MA WARLOW CP WILCOX RG WILLEMS H WOOD EH WYNJONES E ADAMS HP BARTON B BEDFORD RF BICK BL BINGHAM S BROWN BG BRYANT T BURING J CABOT CF CANNER P CHESEBRO J CHRISMAN OD CLAGETT GP COLWELL JA DYKEN M ELLIS D FIELDS WS FURBERG C FUSTER V GOLDMAN S GRANETT J GREEN RM GREEN D HARDY R HARKER LA HARRIS WH HART RG HASS WK HENNEKENS C HILL D HUME M IGLOE MC JOHNSON G JONAS S KNATTERUD G KOHLER TR LEMBO NJ LEWIS D LOCKHART E MAJERUS P MCENANY MT MCKENNA R MEHTA JL MEYER JS MOLONY B MORITZ T NICOLOFF DM NYCZ G ONO H PANTELY GA PHILLIPS SJ RIDKER P ROBERTSON JT ROTHBART R SALZMAN EW SAUTTER RD SCHLANT RC SCHOENBERGER JA SENGEKONTACKET MV SHARMA G STEELE P STEINNAGEL KP STRATTON J SULLIVAN JM TIMMIS G TOOLE JF WALKER MD WEISMAN S WHITE CW WIRECKI M WOMBOLT D WONG R YUSUF S ZADINA K ZUCKER D
Citation: R. Altman et al., COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS, BMJ. British medical journal, 308(6921), 1994, pp. 81-100
ASSOCIATION OF GP IB WITH ACTIN-BINDING PROTEIN DOES NOT REQUIRE GP IX
Authors: LOPEZ JA WEISMAN S SIH T LI CQ SANAN DA
Citation: Ja. Lopez et al., ASSOCIATION OF GP IB WITH ACTIN-BINDING PROTEIN DOES NOT REQUIRE GP IX, Blood coagulation & fibrinolysis, 5(4), 1994, pp. 479-485
TC-99M MDP SCINTIGRAPHY OF PATIENTS UNDERGOING IMPLANT PROSTHETIC PROCEDURES - A FOLLOW-UP-STUDY
Authors: MEIDAN Z WEISMAN S BARON J BINDERMAN I
Citation: Z. Meidan et al., TC-99M MDP SCINTIGRAPHY OF PATIENTS UNDERGOING IMPLANT PROSTHETIC PROCEDURES - A FOLLOW-UP-STUDY, Journal of periodontology, 65(4), 1994, pp. 330-335
GLYCOPROTEIN (GP)-IB-BETA IS THE CRITICAL SUBUNIT LINKING GP-IB-ALPHAAND GP-IX IN THE GP-IB-IX COMPLEX - ANALYSIS OF PARTIAL COMPLEXES
Authors: LOPEZ JA WEISMAN S SANAN DA SIH T CHAMBERS M LI CQ
Citation: Ja. Lopez et al., GLYCOPROTEIN (GP)-IB-BETA IS THE CRITICAL SUBUNIT LINKING GP-IB-ALPHAAND GP-IX IN THE GP-IB-IX COMPLEX - ANALYSIS OF PARTIAL COMPLEXES, The Journal of biological chemistry, 269(38), 1994, pp. 23716-23721
PLATELET GLYCOPROTEIN-(GP)-IB-BETA ASSOCIATES INDEPENDENTLY WITH BOTHGP-IB-ALPHA AND GP-IX IN FORMING THE GP-IB-IX COMPLEX
Authors: LOPEZ JA LI CQ WEISMAN S SANAN DA SIH T CHAMBERS M
Citation: Ja. Lopez et al., PLATELET GLYCOPROTEIN-(GP)-IB-BETA ASSOCIATES INDEPENDENTLY WITH BOTHGP-IB-ALPHA AND GP-IX IN FORMING THE GP-IB-IX COMPLEX, Clinical research, 42(2), 1994, pp. 10000182-10000182
BIOPHARMACEUTICAL CHARACTERIZATION OF A LOW-DOSE (75 MG) CONTROLLED-RELEASE ASPIRIN FORMULATION
Authors: CHARMAN WN CHARMAN SA MONKHOUSE DC FRISBEE SE LOCKHART EA WEISMAN S FITZGERALD GA
Citation: Wn. Charman et al., BIOPHARMACEUTICAL CHARACTERIZATION OF A LOW-DOSE (75 MG) CONTROLLED-RELEASE ASPIRIN FORMULATION, British journal of clinical pharmacology, 36(5), 1993, pp. 470-473
POSTTRANSLATIONAL SULFATION OF TYROSINE RESIDUES IN GLYCOPROTEIN IB-ALPHA
Authors: LOPEZ JA WEISMAN S CHAMBERS M DONG JF
Citation: Ja. Lopez et al., POSTTRANSLATIONAL SULFATION OF TYROSINE RESIDUES IN GLYCOPROTEIN IB-ALPHA, Blood, 82(10), 1993, pp. 10000448-10000448
Risultati: 1-15 |